Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.
Masiello E, Veronesi G, Gallo D, Premoli P, Bianconi E, Rosetti S, Cusini C, Sabatino J, Ippolito S, Piantanida E, Tanda ML, Chiovato L, Wiersinga WM, Bartalena L. Masiello E, et al. Among authors: veronesi g. J Endocrinol Invest. 2018 Dec;41(12):1425-1432. doi: 10.1007/s40618-018-0918-9. Epub 2018 Jun 26. J Endocrinol Invest. 2018. PMID: 29946800
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy.
Bartalena L, Krassas GE, Wiersinga W, Marcocci C, Salvi M, Daumerie C, Bournaud C, Stahl M, Sassi L, Veronesi G, Azzolini C, Boboridis KG, Mourits MP, Soeters MR, Baldeschi L, Nardi M, Currò N, Boschi A, Bernard M, von Arx G; European Group on Graves' Orbitopathy. Bartalena L, et al. Among authors: veronesi g. J Clin Endocrinol Metab. 2012 Dec;97(12):4454-63. doi: 10.1210/jc.2012-2389. Epub 2012 Oct 4. J Clin Endocrinol Metab. 2012. PMID: 23038682 Clinical Trial.
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
Tanda ML, Piantanida E, Liparulo L, Veronesi G, Lai A, Sassi L, Pariani N, Gallo D, Azzolini C, Ferrario M, Bartalena L. Tanda ML, et al. Among authors: veronesi g. J Clin Endocrinol Metab. 2013 Apr;98(4):1443-9. doi: 10.1210/jc.2012-3873. Epub 2013 Feb 13. J Clin Endocrinol Metab. 2013. PMID: 23408569
Masked hypertension in newly diagnosed hypothyroidism: a pilot study.
Piantanida E, Gallo D, Veronesi G, Pariani N, Masiello E, Premoli P, Sassi L, Lai A, Tanda ML, Ferrario M, Bartalena L. Piantanida E, et al. Among authors: veronesi g. J Endocrinol Invest. 2016 Oct;39(10):1131-8. doi: 10.1007/s40618-016-0488-7. Epub 2016 May 19. J Endocrinol Invest. 2016. PMID: 27193102
The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.
Bartalena L, Masiello E, Magri F, Veronesi G, Bianconi E, Zerbini F, Gaiti M, Spreafico E, Gallo D, Premoli P, Piantanida E, Tanda ML, Ferrario M, Vitti P, Chiovato L. Bartalena L, et al. Among authors: veronesi g. J Endocrinol Invest. 2016 Dec;39(12):1445-1451. doi: 10.1007/s40618-016-0516-7. Epub 2016 Jul 27. J Endocrinol Invest. 2016. PMID: 27465670
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?
Bartalena L, Veronesi G, Krassas GE, Wiersinga WM, Marcocci C, Marinò M, Salvi M, Daumerie C, Bournaud C, Stahl M, Sassi L, Azzolini C, Boboridis KG, Mourits MP, Soeters MR, Baldeschi L, Nardi M, Currò N, Boschi A, Bernard M, von Arx G, Perros P, Kahaly GJ; European Group on Graves’ Orbitopathy (EUGOGO). Bartalena L, et al. Among authors: veronesi g. J Endocrinol Invest. 2017 May;40(5):547-553. doi: 10.1007/s40618-017-0608-z. Epub 2017 Feb 7. J Endocrinol Invest. 2017. PMID: 28176220
Physical performance in newly diagnosed hypothyroidism: a pilot study.
Gallo D, Piantanida E, Veronesi G, Lai A, Sassi L, Lombardi V, Masiello E, Premoli P, Bianconi E, Cusini C, Rosetti S, Tanda ML, Toniolo A, Ferrario M, Bartalena L. Gallo D, et al. Among authors: veronesi g. J Endocrinol Invest. 2017 Oct;40(10):1099-1106. doi: 10.1007/s40618-017-0661-7. Epub 2017 Apr 22. J Endocrinol Invest. 2017. PMID: 28434158
Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role?
Piantanida E, Gallo D, Veronesi G, Dozio E, Trotti E, Lai A, Ippolito S, Sabatino J, Tanda ML, Toniolo A, Ferrario M, Bartalena L. Piantanida E, et al. Among authors: veronesi g. Endocr Connect. 2017 Nov;6(8):943-951. doi: 10.1530/EC-17-0304. Epub 2017 Oct 31. Endocr Connect. 2017. PMID: 29089365 Free PMC article.
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.
Premoli P, Tanda ML, Piantanida E, Veronesi G, Gallo D, Masiello E, Rosetti S, Cusini C, Boi F, Bulla J, Rodia R, Mariotti S, Capelli V, Rotondi M, Magri F, Chiovato L, Rocchi R, Campopiano MC, Elisei R, Vitti P, Barbato F, Pilli T, Castagna MG, Pacini F, Bartalena L. Premoli P, et al. Among authors: veronesi g. J Endocrinol Invest. 2020 Jan;43(1):109-116. doi: 10.1007/s40618-019-01088-5. Epub 2019 Jul 20. J Endocrinol Invest. 2020. PMID: 31327128
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe.
Rosetti S, Tanda ML, Veronesi G, Masiello E, Premoli P, Gallo D, Cusini C, Donati S, Sabatino J, Ippolito S, Piantanida E, Bartalena L. Rosetti S, et al. Among authors: veronesi g. J Endocrinol Invest. 2020 Mar;43(3):381-383. doi: 10.1007/s40618-019-01126-2. Epub 2019 Oct 5. J Endocrinol Invest. 2020. PMID: 31587179 No abstract available.
600 results